Antiprotozoal
31 drugs across 19 manufacturers|27 Generic,4 Brand
The Antiprotozoal class contains 31 NDCs from 19 manufacturers (27 generic, 4 brand), at an average NADAC of $9.74 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
31
27G / 4B
Manufacturers
19
Avg $9.7413/unit
Avg 7d Change
-3.59%
Across 24 drugs with changes
7d Activity
of 31 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
19 manufacturers producing drugs in this therapeutic class(3 pricing outliers)
and 7 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Atovaquone market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Antiprotozoal class?
The Antiprotozoal class contains 31 NDCs from 19 manufacturers — 27 generic and 4 brand products.
What is the average price of Antiprotozoal drugs?
The average NADAC for the Antiprotozoal class is $9.7413 per unit across 31 NDCs.
Is generic cheaper than brand in the Antiprotozoal class?
Among products priced per ML, the average generic NADAC in this class is $0.7620, versus $6.8952 for brand — brand products average about 9.0× the generic price.
Which manufacturers make Antiprotozoal drugs?
19 manufacturers make drugs in the Antiprotozoal class. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (5), GlaxoSmithKline LLC (4), Rising Pharma Holdings Inc. (2), Mylan Pharmaceuticals Inc. (2), Prasco Laboratories (2).
How has Antiprotozoal pricing changed recently?
Over the past 7 days, 20 NDCs in this class rose and 4 fell, with a class-wide average change of -3.6%.